Search Results

You are looking at 1 - 5 of 5 items for :

  • Refine by Access: All content x
Clear All
Open access

María Dolores Rodríguez Arnao, Amparo Rodríguez Sánchez, Ignacio Díez López, Joaquín Ramírez Fernández, Jose Antonio Bermúdez de la Vega, Diego Yeste Fernández, María Chueca Guindulain, Raquel Corripio Collado, Jacobo Pérez Sánchez, Ana Fernández González, and ECOS Spain Study Collaborative Investigator Group

Introduction Since the 60s, GH has been the mainstay of treatment for children with GH deficiency (GHD) ( 1 ). With the discovery of recombinant human growth hormone (r-hGH), the treatment has been extended to other conditions, such as Turner

Open access

Pinaki Dutta, Bhuvanesh Mahendran, K Shrinivas Reddy, Jasmina Ahluwalia, Kim Vaiphei, Rakesh K Kochhar, Prakamya Gupta, Anand Srinivasan, Mahesh Prakash, Kanchan Kumar Mukherjee, Viral N Shah, Girish Parthan, and Anil Bhansali

hormones are intact or properly replaced (4, 5, 6) . In addition, GH replacement in these subjects has been shown to reverse many of the abnormalities (7) . There is a paucity of data on recombinant human GH (r-hGH) replacement therapy in acromegaly

Open access

Charlotte Höybye, Andreas F H Pfeiffer, Diego Ferone, Jens Sandahl Christiansen, David Gilfoyle, Eva Dam Christoffersen, Eva Mortensen, Jonathan A Leff, and Michael Beckert

results of a phase II, randomized, active controlled, open label study of safety and efficacy of HM10560A a long acting r-Hgh-HMbib1 conjugate in adult patients with growth hormone deficiency (AGHD) . In ENDO 2015 meeting abstracts . Presented at ENDO

Open access

Ekaterina Koledova, George Stoyanov, Leroy Ovbude, and Peter S W Davies

R. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod device . Journal of Endocrinological Investigation 2016 39 1419 – 1424 . ( https://doi.org/10.1007/s40618-016-0510-0 ) 27406716 10.1007/s40618

Open access

Kennett Sprogøe, Eva Mortensen, David B Karpf, and Jonathan A Leff

://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004975-37/results ) 66 Kang J Kim P Kwak EH Xu M-Y Han O Kim Y Jung SY Kwon S Huh Y Chapel S . 6 month results of a phase II, randomized, active controlled, open label study of safety and efficacy of HM10560A a long acting r-Hgh-HMbib1